Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
KRONOS Worldwide
KRO
$989M
| $521K | ﹤0.01% |
20,214
+19,415
| +2,430% | +$509K |
|
3727
Regenxbio
RGNX
$708M
| $521K | ﹤0.01% |
15,678
+3,317
| +27% | +$99.9K |
|
3728
Intrepid Potash
IPI
$469M
| $520K | ﹤0.01% |
10,918
+2,259
| +26% | +$88.1K |
|
|
YELL
3729
DELISTED
Yellow Corporation Common Stock
YELL
| $520K | ﹤0.01% |
36,211
+548
| +2% | +$7.22K |
|
3730
AMN Healthcare
AMN
$1.4B
| $519K | ﹤0.01% |
10,503
+8,900
| +555% | +$406K |
|
3731
CALL
Itaú Unibanco
ITUB
$87.5B
| $519K | ﹤0.01% |
82,254
-102,662
| -56% | -$655K |
|
3732
Regis Corp
RGS
$70.2M
| $519K | ﹤0.01% |
1,687
+241
| +17% | +$74K |
|
3733
PTC Therapeutics
PTCT
$6.12B
| $518K | ﹤0.01% |
31,054
-26
| -0.1% | -$440 |
|
|
RAD
3734
CALL
DELISTED
Rite Aid Corporation
RAD
| $518K | ﹤0.01% |
13,155
-1,110
| -8% | -$39.7K |
|
|
AXE
3735
DELISTED
Anixter International Inc
AXE
| $518K | ﹤0.01% |
6,813
+6,139
| +911% | +$452K |
|
3736
CALL
Iron Mountain
IRM
$36.1B
| $517K | ﹤0.01% |
13,700
-52,300
| -79% | -$2.08M |
|
3737
CALL
NewMarket
NEU
$8.18B
| $517K | ﹤0.01% |
1,300
+1,000
| +333% | +$405K |
|
|
SNP
3738
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $517K | ﹤0.01% |
7,045
-501
| -7% | -$36.5K |
|
|
BSMX
3739
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $516K | ﹤0.01% |
70,561
+3,257
| +5% | +$27.2K |
|
3740
Caleres
CAL
$487M
| $515K | ﹤0.01% |
15,382
-2,400
| -13% | -$72.9K |
|
3741
Medifast
MED
$141M
| $515K | ﹤0.01% |
7,391
+3,281
| +80% | +$218K |
|
3742
PJT Partners
PJT
$4.38B
| $515K | ﹤0.01% |
11,275
-6,936
| -38% | -$282K |
|
|
XIN
3743
DELISTED
Xinyuan Real Estate
XIN
| $515K | ﹤0.01% |
7,562
+4,537
| +150% | +$267K |
|
3744
PUT
Keurig Dr Pepper
KDP
$40.8B
| $514K | ﹤0.01% |
5,300
+100
| +2% | +$8.97K |
|
3745
Axcelis
ACLS
$4.33B
| $513K | ﹤0.01% |
17,878
+14,210
| +387% | +$447K |
|
3746
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $513K | ﹤0.01% |
7,503
-27,000
| -78% | -$1.69M |
|
|
CRCM
3747
DELISTED
CARE.COM, INC.
CRCM
| $513K | ﹤0.01% |
28,427
+8,515
| +43% | +$149K |
|
3748
Natural Gas Services Group
NGS
$477M
| $512K | ﹤0.01% |
19,534
+1,763
| +10% | +$47K |
|
3749
Wave Life Sciences
WVE
$1.2B
| $512K | ﹤0.01% |
14,574
+5,499
| +61% | +$160K |
|
|
WMGI
3750
DELISTED
Wright Medical Group Inc
WMGI
| $512K | ﹤0.01% |
23,078
-72,171
| -76% | -$1.78M |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.